Saquinavir: too early to market?
Steele
F R
FR
D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D007546:Isoquinolines / Q000627:therapeutic use*; D008389:Marketing of Health Services; D011804:Quinolines / Q000627:therapeutic use*; D019258:Saquinavir; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D019258:Saquinavir